Genotype to phenotype consequences in MERS-CoV
University of Liverpool · 13.08.2026
DOI: 10.17638/03198783 ↗Kurz gefasst
Fachartikel in der Zeitschrift University of Liverpool, erschienen am 13.08.2026. Verfasst von Dempsey und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Middle East respiratory syndrome coronavirus (MERS-CoV) was first identified in Saudi Arabia in 2012 and has a reported mortality rate of 36%, making it the most pathogenic human coronavirus known. Dromedary camels are the major reservoir of MERS-CoV, with regular spillover into humans presenting a significant public health risk. Human-to-human transmission has been confirmed between close contacts in healthcare settings and those residing in the same household. Currently, there are no specific medical countermeasures available to treat MERS-CoV infection. Much of the MERS-CoV research to date has focussed on the EMC/2012 reference strain, which is phylogenetically classified as clade A. However, clade A viruses have been considered extinct since 2015, while the majority of MERS-CoV strains causing human infections belong to clade B, lineage 5. It was hypothesised that naturally occurring Spike mutations identified in human MERS-CoV infections would result in phenotypic differences in virus entry and neutralisation. It was also hypothesised that contemporary MERS-CoV strains would replicate and adapt differently in humans relative to EMC/2012. Therefore, it is important to understand the genotype to phenotype consequences in contemporary MERS-CoV strains to increase knowledge surrounding human infections. This will also facilitate a more effective response to virus adaptation and improve pandemic preparedness. Here, two tools were developed to study contemporary MERS-CoV: a lentiviral pseudotyping system and a yeast-based reverse genetics system. Pseudotypes were used to characterise naturally occurring Spike mutations identified in human MERS-CoV sequences. Split GFP cell-cell fusion assays demonstrated that I529T, E536K, L745F and Ins885 improved MERS-CoV entry. While microneutralisation assays demonstrated that L411F, T424I, L506F, L745F and T746K increased resistance to neutralisation by pooled patient sera. A recombinant MERS-CoV (rMERS-CoV) full-length infectious clone carrying a representative clade B, lineage 5 sequence was generated via reverse genetics. rMERS-CoV was subsequently used to study infectivity, replication and genetic stability of contemporary strains in human cells. Replication of rMERS-CoV in primary human nasal epithelial cells was found to be improved relative to EMC/2012. Additionally, the host response to rMERS-CoV infection was investigated in Calu-3 cells, whereby significantly upregulated genes included those associated with the innate immune response and cellular stress response elements. Ultimately, the evidence presented here indicates contemporary MERS-CoV strains may be becoming more infectious in humans, while also carrying mutations that facilitate immune evasion. Crucially, contemporary MERS-CoV replicated to significantly higher titres than EMC/2012 in an in vitro model of the upper respiratory tract. These findings highlight the importance of continued surveillance and study of contemporary strains to manage the pandemic threat posed by MERS-CoV. Furthermore, in addition to being used alongside surveillance systems, the tools developed in this thesis could be used in the development of therapeutics to treat MERS disease.
Schlagwörter
Zitieren
APA
Dempsey, & Rachael (2026). Genotype to phenotype consequences in MERS-CoV. University of Liverpool. https://doi.org/10.17638/03198783
Vancouver
Dempsey, Rachael. Genotype to phenotype consequences in MERS-CoV. University of Liverpool. 2026. doi:10.17638/03198783
BibTeX
@article{Dempsey2026,
author = {Dempsey and Rachael},
title = {Genotype to phenotype consequences in MERS-CoV},
journal = {University of Liverpool},
year = {2026},
doi = {10.17638/03198783}
}
EUVIMED